We hypothesized that both sterile solutions and foreign body reaction to the peritoneal dialysis catheter are associated with inflammatory changes in rats exposed to hypertonic solution.
♦ Methods
Four hypertonic solutions (30 – 40 mL) were injected daily via needle and syringe over 20 weeks in 4 groups of rats: 4.25% standard clinical solution (LAC), LAC plus pyridoxamine (PYR), LAC plus ethyl pyruvate (EP), and a biocompatible 4% dextrose solution (BIC). Two groups received catheters: a non-injected 4-week catheter group (C4) and a group injected for 20 weeks with the BIC solution (CI). Control animals (CON) were not injected. In the C4 group, adherent cells were separated from the catheter and examined by culture and electron microscopy to ensure that animals were bacteria free prior to exposure to solution. Animals underwent transport experiments to determine mass transfer coefficients of mannitol (MTCM) and albumin (MTCA), osmotic filtration flux (Josm), and hydrostatic pressure-driven flux (Jp). After euthanasia, tissues were examined for submesothelial thickness, vascular density, and immunohistochemistry for various cytokines.
♦ Results
The catheter cell layer was free of bacteria and consisted of macrophages, lymphocytes, mesothelial cells, and fibroblastic cells. Marked differences in angiogenesis and submesothelial thickening were noted for the catheter groups. Transport differences were mixed: MTCM was significantly less for the CI group and MTCA was variable among the groups. There were no differences among groups for Josm or Jp. Inflammatory markers in the catheter-adherent cells correlated with inflammatory changes in the tissue. These data demonstrate significant changes in submesothelial thickness, angiogenesis, transport function, and inflammatory markers between animals injected with sterile solutions over 20 weeks with and without catheters.
♦ Conclusions
An indwelling catheter amplifies peritoneal inflammation from dialysis solutions through a foreign body reaction. Our data also suggest that additives to existing solutions may have limited the effect on inflammatory response to non-biocompatible solutions.
WitowskiJ., WisniewskaJ., KorybalskaK., BenderT.O., BreborowiczA., GahlG.M.Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.J Am Soc Nephrol2001; 12: 2434–41.
2.
WitowskiJ., BenderT.O., Wisniewska-ElnurJ., KsiazekK., Passlick-DeetjenJ., BreborowiczA.Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.Perit Dial Int2003; 23: 381–90.
3.
MortierS., FaictD., LameireN.H., deVrieseA.S.Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.Kidney Int2005; 67: 1559–65.
4.
BoulangerE., WautierM.P., GaneP., MarietteC., DevuystO., WautierJ.L.The triggering ofhuman peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.Nephrol Dial Transplant2004; 19: 2208–16.
5.
FlessnerM.F.Sterile inflammation and longevity of the peritoneal barrier.Clin Nephrol2007; 68: 341–8.
6.
FlessnerM.F., CreditK., HendersonK., VanpeltH., PotterR., HeZ.Peritoneal changes after exposure to sterile solutions by catheter.J Am Soc Nephrol2007; 18: 2294–302.
SwartzR., MessanaJ., HolmesC., WilliamsJ.Biofilm formation on peritoneal catheters does not require the presence of infection.Trans Am Soc Artif Intern Organs1991; 37: 626–34.
9.
ZweersM.M., SplintL.J., KredietR.T., StruijkD.G.Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat.Nephrol Dial Transplant2001; 16: 651–4.
10.
van WestrhenenR., ZweersM.C., KunneC., De WaartD.R., Van der WalA.C., KredietR.A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.Perit Dial Int2008; 28: 487–96.
11.
DedrickR.L.Interspecies scaling of regional drug delivery.J Pharm Sci1986; 75: 1047–52.
12.
TunneyM.M., PatrickS., CurranM.D., RamageG., AndersonN., DavisR.I. eds. Detection of Prosthetic Joint Biofilm Infection Using Immunological and Molecular Techniques.San Diego: Academic Press; 1999.
13.
FlessnerM.F., ChoiJ., HeZ., CreditK.Physiological characterization of human ovarian cancer cells in a rat model of intraperitoneal antineoplastic therapy.J Appl Physiol2004; 97: 1518–26.
14.
FlessnerM.F., ChoiJ., VanpeltH., HeZ., CreditK., HenegarJ.Correlating structure with solute and water transport in a chronic model of peritoneal inflammation.Am J Physiol Renal Physiol2006; 290: F232–F240.
15.
VogelJ., SperandioM., PriesA.R., LinderkampO., GaehtgensP., KuschinskyW.Influence of the endothelial glycocalyx on cerebral blood flow in mice.J Cerebral Blood Flow Metab2000; 20: 1571–8.
16.
RehmM., SahlerS., LotschM., WelschU., ConzenP., JacobM.Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed.Anesthesiology2004; 100: 1211–23.
17.
BrueggerD., JacobM., RehmM., LoetschM., WelschU., ConzenP.Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts.Am J Physiol Heart Circ Physiol2004; 289: H1993–H1999.
18.
AlbrektssonA., BazarganiF., WieslanderA., BraideM.Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose.ASAIO J2006; 52: 276–81.
19.
JorresA., BenderT.O., FinnA., WitowskiJ., FrohlichS., GahlG.M.Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.Kidney Int1998; 54: 2184–93.
20.
ErixonM., LindenT., KjellstrandP., CarlssonO., ErnebrantM., ForsbackG.PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization.Perit Dial Int2004; 24: 392–8.
21.
LedeboI., WieslanderA., DeppischR.GDPs and AGEs: local and systemic effects in PD patients.Contrib Nephrol2003; 140: 38–46.
22.
MiyajiT., HuX., YuenP.S.T., MuramatsuY., IyerS., HewittS.M.Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice.Kidney Int2003; 64: 1620–31.
23.
UlloaL., OchaniM., YangH., TanovicM., HalperinD., YangR.Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.Proc Natl Acad Sci U S A2002; 99: 12351–6.
24.
KhalifahR.G., BaynesJ.W., HudsonB.G.Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.Biochem Biophys Res Commun1999; 257: 251–8.
25.
DegenhardtT.P., AldersonN.L., ArringtonD.D., BeattieR.J., BasgenJ.M., SteffesM.W.Pyridoxamine inhibits early renal disease and dyslipidemia in streptozotocin-diabetic rat.Kidney Int2002; 61: 939–50.
26.
KakutaT., TanakaR., SatohY., IzuharaY., InagiR., NangakuM.Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.Kidney Int2005; 68: 1326–36.
27.
TopleyN., AlobaidiH.M., DaviesM., ColesG.A., WilliamsJ.D., LloydD.The effect of dialysate on peritoneal phagocyte oxidative metabolism.Kidney Int1988; 34: 404–11.
28.
JonassonP., BraideM.Acute in vivo toxicity of heat-sterilized glucose peritoneal dialysis fluids to rat peritoneal macrophages.Perit Dial Int1998; 18: 376–81.
29.
HekkingL.H.P., AaldersM.C., Van GelderopE., ZweersM.M., StruijkD.G., HavenithC.E.G.Effect of peritoneal dialysis fluid measured in vivo in a rat-model of continuous peritoneal dialysis.Adv Perit Dial1998; 14: 14–18.
30.
MortierS., LameireN.H., deVrieseA.S.The effects of peritoneal dialysis solutions on peritoneal host defense.Perit Dial Int2004; 24: 123–38.
31.
MusiB., BraideM., CarlssonO., WieslanderA., AlbrektssonA., KettelerM.Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.Perit Dial Int2004; 24: 37–47.
32.
MortierS., FaictD., SchalkwijkC.G., LamiereN.H., deVrieseA.S.Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane.Kidney Int2004; 66: 1257–65.
33.
De VrieseA.S., MortierS., LameireN.H.Neoangiogenesis in the peritoneal membrane: does it play a role in ultrafiltration failure?Nephrol Dial Transplant2001; 16: 2143–5.
34.
MateijsenM.A., van der WalA.C., HendriksP.M., ZweersM.M., MulderJ., StruijkD.G.Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.Perit Dial Int1999; 19: 517–25.
35.
FlessnerM.F.Endothelial glycocalyx and the peritoneal barrier.Perit Dial Int2008; 28: 6–12.
AltieriD.C., PlesciaJ., PlowE.F.The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin and promotes leukocyte adhesion.J Biol Chem1993; 268: 1847–53.
38.
TangL., EatonJ.W.Natural responses to unnatural materials: a molecular mechanism for foreign body reactions.Mol Med1999; 5: 351–8.
39.
TangL., JenningsT.A., EatonJ.W.Mast cells mediate acute inflammatory responses to implanted biomaterials.Proc Natl Acad Sci U S A1998; 95: 8841–6.
40.
TangL., ChesneyJ., SherryB., EatonJ.W.The pivotal roles of cytokines in the recruitment and adhesion of inflammatory cells to implanted biomaterials.Transactions of the Society for Biomaterials1997; 23: 127.
41.
Yanez-MoM., Lara-PezziE., SelgasR., Ramierez-HuescaM., Dominguez-JimenezC., Jimenez-HeffernanJ.A.Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.N Engl J Med2003; 348: 403–13.
42.
AroeiraL.S., AguileraA., Sanchez-TomeroJ.A., BajoM.A., del PesoG., Jimenez-HeffernanJ.A.Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.J Am Soc Nephrol2007; 18: 2004–13.
43.
Lopez-CabreraM., AguileraA., AroeiraL.S., Ramirez-HuescaM., Perez-LozanoM.L., Jimenez-HeffernanJ.A.Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.Perit Dial Int2006; 26: 26–34.
